Gastroesophageal reflux in lung transplantation

Gastroesophageal reflux disease (GERD) in lung transplant recipients has been associated with chronic lung allograft dysfunction (CLAD). CLAD is a leading cause of mortality in lung transplant recipients, and it is probably the result of a variety of immune, infectious, and inflammatory injuries. GE...

Descripción completa

Detalles Bibliográficos
Autores: Izquierdo-Cuervo, Sheila, Tello-Mena, Sandra, Mora Cuesta, Víctor Manuel|||0000-0002-8161-0462
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universidad de Cantabria (UC)
Repositorio:UCrea Repositorio Abierto de la Universidad de Cantabria
Idioma:inglés
OAI Identifier:oai:dnet:ucreareposit::1dfb33503ccc7f197ce7febe70e9dfe4
Acceso en línea:https://hdl.handle.net/10902/40207
Access Level:acceso abierto
Palabra clave:Antireflux surgery
Chronic lung allograft dysfunction
Fundoplication
Gastroesophageal reflux disease
Lung transplantation
Descripción
Sumario:Gastroesophageal reflux disease (GERD) in lung transplant recipients has been associated with chronic lung allograft dysfunction (CLAD). CLAD is a leading cause of mortality in lung transplant recipients, and it is probably the result of a variety of immune, infectious, and inflammatory injuries. GERD may contribute to CLAD since it is associated with a higher risk for post-transplant aspiration. Aspiration induces an inflammatory cascade in the lung allograft, thereby causing acute rejection. Recurrent episodes of acute rejection and allograft injury may then contribute to chronic rejection, resulting in graft failure. Poorer outcomes after transplantation, including early allograft injury, early rehospitalization, and chronic rejection are potentially modifiable risk factors for post-transplant mortality. In patients with GERD, antireflux surgery may help preserve post-transplant lung function, improve immune response, and reduce the incidence of bronchiolitis obliterans syndrome and mortality. Early fundoplication improves survival and reduces the incidence of CLAD in lung transplant recipients.